Free Trial
NYSEARCA:KURE

KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News

$14.01 +0.27 (+1.97%)
As of 04:10 PM Eastern

About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE)

Key Stats

Today's Range
$13.85
$14.01
50-Day Range
$13.20
$16.36
52-Week Range
$12.91
$20.51
Volume
2,721 shs
Average Volume
10,527 shs
Market Capitalization
$44.83 million
Assets Under Management
$34.73 million
Dividend Yield
0.07%
Net Expense Ratio
0.65%
Aggregate Rating
Buy

ETF Overview

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.

KraneShares MSCI All China Health Care Index ETF Expenses

TypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.78%0.57%0.55%0.51%0.52%
Other Expenses0.01%0.30%0.49%0.57%0.54%
Total Expense0.79%0.70%0.71%0.73%0.71%
Fee Waiver-0.14%-0.45%-0.51%-0.66%-0.56%
Net Expense0.65%0.61%0.61%0.58%0.59%
Receive KURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter.

KURE ETF News Headlines

Ignore every stock…
Stocks have been on a tear in 2024… And there’s plenty of great opportunities out there. But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity. The current GOLD supercycle You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down. But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else. The last time things aligned like this on gold it surged 536%
KURE KraneShares MSCI All China Health Care Index ETF
See More Headlines

KURE ETF - Frequently Asked Questions

KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 at the beginning of the year. Since then, KURE stock has decreased by 1.3% and is now trading at $14.01.
View the best growth stocks for 2025 here
.

Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA).

Fund Details

Issuer
KraneShares
Fund Name
KraneShares MSCI All China Health Care Index ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:KURE
Inception Date
1/31/2018
Fund Manager
Mark Schlarbaum
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
MSCI China All Shares Health Care 10/40 Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
61

Fund Statistics

Assets Under Management
$34.73 million
Average Daily Volume
$10,619.70
Discount/Premium
0.11%

Administrator, Advisor and Custodian

Administrator
SEI Investments Global Funds Services
Advisor
Krane Funds Advisors, LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
N/A
Short Interest
25,300 shs

Miscellaneous

Beta
0.69
Creation Unit
50,000
Creation Fee
$1,320.00
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Top 10 KURE Holdings

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Holding Weight: 8.13%
  • Jiangsu Hengrui Medicine Co., Ltd.
    Holding Weight: 7.92%
  • BeiGene, Ltd.
    Holding Weight: 6.38%
  • WuXi Biologics (Cayman) Inc.
    Holding Weight: 5.00%
  • WuXi AppTec Co., Ltd.
    Holding Weight: 3.73%
  • Innovent Biologics, Inc.
    Holding Weight: 3.69%
  • Zhangzhou Pientzehuang Pharmaceutical., Ltd
    Holding Weight: 3.52%
  • CSPC Pharmaceutical Group Limited
    Holding Weight: 3.26%
  • Aier Eye Hospital Group Co., Ltd.
    Holding Weight: 3.19%
  • Akeso, Inc.
    Holding Weight: 3.06%

KURE Sector Exposure

KURE Industry Exposure


This page (NYSEARCA:KURE) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners